Therefore, the clinical relevance of this mouse model of IEC-specific HNF4A deletion may be limited but nonetheless provides an opportunity to investigate general principles of HNF4A-microbiota interaction during early subclinical stages of IBD. Here, HNF4A is linked to inflammatory bowel disease.